Observational Study for ALS and Related Disorders

This study, called CAPTURE, is looking at information already collected in your medical records to better understand amyotrophic lateral sclerosis (ALS) and related conditions like primary lateral sclerosis and progressive muscular atrophy. Researchers are not testing any new treatments or interventions. Instead, they are using a standardized approach to gather health information from electronic health records (EHRs) to learn about how these diseases progress over time. You may be able to join if you have ALS or a related disorder, are 18 or older, receive care at a clinic that uses Epic for its EHR, and can provide informed consent. The study aims to see how well a specific toolkit works for collecting and using this health record data for research over 12 months. The current status of this study is unclear.

Study design
This is an observational study, meaning no interventions are being tested. It plans to include up to 1200 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The primary endpoint is measured at 12 months, which suggests a follow-up period of at least that long.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT03489278

Clinical Procedures to Support Research in ALS

Recruiting
Not specifiedAges 18+Observational
University of Miami
~1,200 participants
Updated 2026-06-15 on ClinicalTrials.gov

At a glance

Recruiting sites
10 of 11 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Using the ALS Toolkit for collecting and using electronic health record data for research purposes
Measured over 12 months
Amyotrophic Lateral Sclerosis
ALS-Frontotemporal Dementia
Primary Lateral Sclerosis
Progressive Muscular Atrophy
11 sites across 8 states
California3
North Carolina2
Florida1
Kansas1
Minnesota1
New York1
Oregon1
Texas1
  • Michael Benatar, MBChB, MS, DPhil · PRINCIPAL_INVESTIGATOR · University of Miami

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Diagnosis of ALS or a related disorder (e.g. primary lateral sclerosis, progressive muscular atrophy).
Receiving care at a clinical center that uses Epic as its EHR.
Able and willing to provide informed consent (or informed consent obtainable from a designated proxy).

Exclusion

Inability to understand English and/or Spanish
  • Using the ALS Toolkit for collecting and using electronic health record data for research purposes12 months